Pseudomonas aeruginosa Virulence and Antimicrobial Resistance
Author:
- 1 January 2014
- journal article
- editorial
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 42 (1) , 201-202
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Risk of Developing Pneumonia Is Enhanced by the Combined Traits of Fluoroquinolone Resistance and Type III Secretion Virulence in Respiratory Isolates of Pseudomonas aeruginosa*Critical Care Medicine, 2014
- Differentiation in Quinolone Resistance by Virulence Genotype in Pseudomonas aeruginosaPLOS ONE, 2012
- International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009American Journal of Infection Control, 2012
- Clinical outcomes of type III Pseudomonas aeruginosa bacteremia*Critical Care Medicine, 2012
- Pseudomonas aeruginosa Cytotoxin ExoU Is Injected into Phagocytic Cells during Acute PneumoniaInfection and Immunity, 2010
- Prevalence of Type III Secretion Protein Exoenzymes and Antimicrobial Susceptibility Patterns from Bloodstream Isolates of Patients withPseudomonas aeruginosaBacteremiaJournal of Chemotherapy, 2008
- Pseudomonas aeruginosa Induces Localized Immunosuppression during PneumoniaInfection and Immunity, 2008
- Persistent Infection with Pseudomonas aeruginosa in Ventilator-associated PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosaClinical Microbiology and Infection, 2008
- Type III Secretion System–Associated Toxins, Proteases, Serotypes, and Antibiotic Resistance ofPseudomonas aeruginosaIsolates Associated with KeratitisCurrent Eye Research, 2006